Angiotensin-II-Type-1-Receptor-Blockers, page 10

Search results for Angiotensin-II-Type-1-Receptor-Blockers

Found 1399 articles. Showing from 91 to 100.

Hypertension (2011-04-21)
Pressor and renal hemodynamic effects of the novel angiotensin A peptide are angiotensin II type 1A receptor dependent.

Kidney international (2008-10-15)
Candesartan and renal protection: more than blocking angiotensin type 1 receptor?

Nephrology, dialysis, transplantation (2011-10-31)
Combined vascular effects of HMG-CoA reductase inhibitor and angiotensin receptor blocker in non-diabetic patients undergoing peritoneal dialysis.

Hypertension (2008-07-28)
Efficacy and safety of the Angiotensin receptor blocker valsartan in children with hypertension aged 1 to 5 years.

Nephrology (2008-03-04)
Urinary kallikrein excretion is related to renal function change and inflammatory status in chronic kidney disease patients receiving angiotensin II receptor blocker treatment.

Annals of internal medicine (2009-12-16)
Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease.

MedGenMed (2008-03-03)
Characteristics of patients prescribed angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or the combination at an urban medical center.

Journal of the American Society of Nephrology (2007-01-29)
Angiotensin II type 1 receptor blockade inhibits the development and progression of HIV-associated nephropathy in a mouse model.

Diabetes (2012-03-23)
Candesartan cilexetil improves angiotensin II type 2 receptor-mediated neurite outgrowth via the PI3K-Akt pathway in fructose-induced insulin-resistant rats.

Journal of hypertension (2005-05-16)
Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients.

Filters

Journals

Categories

Subjects

Year of publication

Español | English

© Galenicom 1999-2013